Comparison of Biotech in the US and in Europe | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Cancer On The Rise Globally: 15 Million Cancer Cases Diagnosed in 2013

New Findings in Endometrial Cancer: Mutations, Molecular Types and Immune Responses Evoked by Mutation-prone Endometrial, Ovarian Cancer Subtypes »

Comparison of Biotech in the US and in Europe

June 2, 2015 by 2012pharmaceutical

Comparison of Biotech in the US and in Europe

Reporter: Aviva Lev-Ari, PhD, RN

BIOTECH NUMBERS: US VS EUROPE

SOURCE

https://biotechlikemind.co/blog/biotech-numbers-us-vs-europe

Posted in Bio Instrumentation in Experimental Life Sciences Research, BioBanking, Bioengineering & reverse engineering design, BioIT: BioInformatics | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 9,459 other subscribers
Recent Posts
- Creating a Twitter Space for @pharma_BI for Live Broadcasts March 14, 2023
- The Vibrant Philly Biotech Scene: Recent Happenings & Deals March 11, 2023
- Peak oxygen uptake (VO2peak) quantified fitness: Lifelong and late-onset athletes had higher VO2peak than non-athletes March 7, 2023
- Merck’s sotatercept overachieves, PCSK9 inhibitor passes phase 2 March 6, 2023
- Bacterial multidrug resistance problem solved by a broad-spectrum synthetic antibiotic March 1, 2023
- Genetic variation causes human lupus, systemic lupus erythematosus (SLE) February 23, 2023
- Mimicking vaginal cells and microbiome interactions on chip microfluidic culture February 14, 2023
- Press Release for Five Bilingual BioMed e-Series in English and in Spanish January 29, 2023
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: